Last reviewed · How we verify
Matching placebo of AK0529 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Matching placebo of AK0529 (Matching placebo of AK0529) — Shanghai Ark Biopharmaceutical Co., Ltd.. This is a placebo control formulation with no active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Matching placebo of AK0529 TARGET | Matching placebo of AK0529 | Shanghai Ark Biopharmaceutical Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Matching placebo of AK0529 CI watch — RSS
- Matching placebo of AK0529 CI watch — Atom
- Matching placebo of AK0529 CI watch — JSON
- Matching placebo of AK0529 alone — RSS
Cite this brief
Drug Landscape (2026). Matching placebo of AK0529 — Competitive Intelligence Brief. https://druglandscape.com/ci/matching-placebo-of-ak0529. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab